Skip to main content

Table 2 Prognostic markers involved in regulating proliferation in ESCC as reported in original studies

From: Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review

Marker

References

Sample size

Clinical stage

OS

DFS

Analytic methods

HR

95% CI

P value

HR

95% CI

P value

EGFR

Zhang et al. [10]

441

IB-IIIC

1.452

1.137–1.855

0.003

1.351

1.057–1.728

0.016

Cox proportional hazards model

Zhang et al. [19]

128

II–IV

–

–

>0.05

–

–

–

Log-rank test

Cao et al. [29]

315

I–IV

1.614

1.027–2.536

0.038

–

–

–

Cox proportional hazards model (univariate)

Shang et al. [30]

590

I-III

2.652

1.708-4.118

0.00001

–

–

–

Cox proportional hazards model

Jiang et al. [31]

96

–

–

–

0.007

–

–

0.006

Log-rank test

Xu et al. [32]

87

I–III

1.728

1.011–2.955

0.046

–

–

–

Cox proportional hazards model

HER2

Zhang et al. [19]

128

II–IV

–

–

>0.05

–

–

–

Log-rank test

Mimura et al. [33]

66

0–IV

0.92

0.35–2.41

0.861

–

–

–

Cox proportional hazards model,

Sunpaweravong et al. [34]

55

II–IV

–

–

0.04

–

–

–

Log-rank test

Zhan et al. [35]

145

I–IV

–

–

0.036

–

–

–

Log-rank test

p-mTOR

Hirashima et al. [36]

143

I–III

2.92

1.48–5.78

0.002

–

–

–

Cox proportional hazards model

Kim et al. [37]

165

I–IV

1.47

0.92-2.35

0.104

1.67

1.07–2.62

0.025

Cox proportional hazards model

Li et al. [38]

105

I–IV

–

–

0.022

–

–

0.014

Log-rank test

Li et al. [39]

77

II–III

2.814

1.553–5.097

0.001

2.438

1.368–4.347

0.003

Cox proportional hazards model

P16

Mathew et al. [11]

50

I–IV

–

–

>0.05

–

–

–

Log-rank test

Okamoto et al. [20]

86

I–IV

–

–

0.19

–

–

0.14

Cox proportional hazards model (univariate)

Cao et al. [42]

105

I–III

4.23

1.75–8.54

0.03

2.52

1.12–5.71

0.02

Cox proportional hazards model

Guan et al. [43]

90

I–IV

0.234

0.086–0.637

0.004

–

–

–

Cox proportional hazards model

Takeuchi et al. [44]

90

I–III

0.312

–

0.003

–

–

–

Cox proportional hazards model

Guner et al. [45]

53

I–III

0.410

0.203–0.828

0.013

–

–

–

Cox proportional hazards model (univariate)

Fujiwara et al. [46]

60

I–IV

0.597

0.287–1.032

0.067

–

–

–

Cox proportional hazards model

P21

Shiozaki et al. [12]

69

I–IV

0.381

0.123–0.995

0.049

–

–

–

Cox proportional hazards model

  1. ESCC esophageal squamous cell carcinoma, EGFR epidermal growth factor receptor, HER2 human epidermal growth factor receptor-2, p-mTOR phosphorylated mammalian target of rapamycin, OS overall survival, DFS disease-free survival, HR hazard ratio, CI confidence interval, – no data